SAMSCA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug SAMSCA contains one active pharmaceutical ingredient (API):

1	Tolvaptan UNII 21G72T1950 - TOLVAPTAN
	Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP.
	Read more about Tolvaptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SAMSCA Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03XA01	Tolvaptan	C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists
Discover more medicines within C03XA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02370468, 02370476
EE	Ravimiamet	1433933, 1433944, 1433955, 1433966, 1753624, 1753635, 1847392, 1847404
ES	Centro de información online de medicamentos de la AEMPS	09539001, 09539003, 109539007
FI	Lääkealan turvallisuus- ja kehittämiskeskus	038376, 038399, 165319, 553802
FR	Base de données publique des médicaments	63371428, 63790853, 67412139
GB	Medicines & Healthcare Products Regulatory Agency	159346, 159352, 367567
HK	Department of Health Drug Office	59910, 59911
IT	Agenzia del Farmaco	039551015, 039551027, 039551039, 039551041, 039551054, 039551066, 039551078, 039551080
JP	医薬品医療機器総合機構	2139011D1022, 2139011F3026, 2139011F4022, 2499012F2029
LT	Valstybinė vaistų kontrolės tarnyba	1050734, 1050735, 1050736, 1050737, 1084008, 1084009, 1086390, 1086391
PL	Rejestru Produktów Leczniczych	100316415, 100316421, 100417553
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67142001, W67142002, W67143001, W67143002
TR	İlaç ve Tıbbi Cihaz Kurumu	8680683010019, 8680683010026, 8680683010033, 8680683010040
US	FDA, National Drug Code	59148-020, 59148-021